Clinical Trial

To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of initial combination therapy with DWP16001 and DWC202518 compared to DWP16001 monotherapy and DWC202518 monotherapy in patients with Type 2 Diabetes Mellitus
Trial Details
NCT Number NCT07619833
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions T2DM (Type 2 Diabetes Mellitus)
Enrollment 510 participants
Start Date 2026-06
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-02